| 1 |
NCT02964793 |
Not yet recruiting |
Effects of Serial Plotting on Fundal Height Charts on Identification and Outcomes of Small for Gestational Age Infants |
- Small for Gestational Age
|
- Other: intervention group
|
Interventional |
Not Applicable |
- University Hospital, Grenoble
- Institut National de la Santé Et de la Recherche Médicale, France
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Rate detection of FGR
- Number of participants presenting the following perinatal outcomes
- Performances of screening policies
- (and 2 more...)
|
10000 |
Female |
18 Years and older (Adult, Senior) |
NCT02964793 |
38RC 14.456 |
HPAG |
January 1, 2018 |
January 1, 2019 |
January 1, 2020 |
November 16, 2016 |
October 6, 2017 |
|
- Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux
Bordeaux, France - Department of Obstetrics and Gynecology, Caen University Hospital, Caen
Caen, France - Department of Obstetrics and Gynecology, Louis Mourier Hospital, Assistance Publique-Paris Hospitals (APHP)
Colombes, France - (and 13 more...)
|
| 2 |
NCT03245333 |
Recruiting |
A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA) |
- Small for Gestational Age Infant
|
- Drug: Recombinant Human Growth Hormone Injection
|
Interventional |
Phase 3 |
- GeneScience Pharmaceuticals Co., Ltd.
- Tongji Hospital
- Beijing Children's Hospital
- (and 3 more...)
|
Industry / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change of height standard deviation score for chronological age (△Ht SDSCA)
- Height（Ht）at the end of treatment
- Annualized height velocity (HV)
- (and 3 more...)
|
120 |
All |
24 Years to 90 Years (Adult, Senior) |
NCT03245333 |
GenSci 030 CT-III |
|
December 2014 |
December 2017 |
|
August 10, 2017 |
December 12, 2017 |
|
- Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China - The first affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China - The Children's Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China - (and 2 more...)
|
| 3 |
NCT02887664 |
Not yet recruiting |
The Correlation Between the n-6:n-3 Ratio and Inflammatory Markers in Small for Gestational Age (SGA) Infants Compared With Appropriate for Gestational Age (AGA) Infants |
- Small for Gestational Age Infants
- Appropriate for Gestational Age Infants
|
|
Observational |
|
- Tel-Aviv Sourasky Medical Center
|
Other |
- Observational Model: Case-Control
- Time Perspective: Cross-Sectional
|
- Cord blood analysis
- Maternal blood analysis
|
60 |
Female |
18 Years to 60 Years (Adult) |
NCT02887664 |
0285-16-TLV-DM |
|
June 2018 |
September 2018 |
January 2019 |
September 2, 2016 |
April 11, 2018 |
|
|
| 4 |
NCT01491854 |
Recruiting |
Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age |
- Short Children Born Small for Gestational Age (SGA)
|
|
Interventional |
Not Applicable |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Evaluate the long-term effect of growth hormone treatment on the development of diabetes after end of therapy.
- To evaluate the incidence of anti-rhGH antibodies and anit-HCP antibodies after 6 months after termination of growth hormone treatment.
|
200 |
All |
4 Years and older (Child, Adult, Senior) |
NCT01491854 |
EP00-402 |
SGA |
July 2009 |
July 2031 |
July 2031 |
December 14, 2011 |
June 9, 2017 |
|
- Sandoz Investigational Site
Hradec Králové, Czechia - Sandoz Investigational Site
Prague, Czechia - Sandoz Investigational Site
Ústí nad Labem, Czechia - (and 24 more...)
|
| 5 |
NCT02931591 |
Not yet recruiting |
Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children |
- Small for Gestational Age
|
- Drug: Metformin
- Drug: Growth Hormone
- Drug: Placebo
|
Interventional |
Not Applicable |
- Cambridge University Hospitals NHS Foundation Trust
- Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark
- Birmingham Women's and Children's NHS Foundation Trust
- The National Children's Hospital, Tallaght
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- IGF-1 response
- Height velocity
- Insulin sensitivity
- Insulin secretion
|
24 |
All |
4 Years to 10 Years (Child) |
NCT02931591 |
SGA Metformin Study |
|
November 2016 |
November 2019 |
June 2020 |
October 13, 2016 |
October 14, 2016 |
|
|
| 6 |
NCT02421445 |
Recruiting |
Analyses of Human Milk From Mother Delivering Small for Gestational Age (SGA) and Appropriate for Gestational Age (AGA) Infants |
- Small for Gestational Age (SGA) Infants
- Appropriate for Gestational Age (AGA) Infants
|
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Longitudinal milk samples' analyses
- Assessment of dietary intake
- Maternal milk composition analysis
- Exploration of other parameters
|
300 |
Female |
18 Years to 40 Years (Adult) |
NCT02421445 |
12.23 NRC |
|
April 2015 |
December 2017 |
December 2017 |
April 20, 2015 |
November 30, 2016 |
|
- Muzumdar Shaw Medical Centre
Delhi, Bangalore, India - Sir Ganga Ram Hospital
New Delhi, India
|
| 7 |
NCT02770157 |
Recruiting |
Efficacy and Safety of DA-3002 in Short Children Borns SGA. |
- Infant, Small for Gestational Age
|
- Drug: DA-3002
- Drug: Genotropin®
|
Interventional |
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Annualized height velocity(cm/year) after 52 weeks.
- Annualized height velocity(cm/year) after 26 weeks.
- Changes in height standard deviation score after 52 weeks
- (and 3 more...)
|
75 |
All |
4 Years to 16 Years (Child) |
NCT02770157 |
DA3002_SGA_III |
SGA |
February 2016 |
April 2019 |
|
May 12, 2016 |
September 19, 2017 |
|
- Samsung Medical Center
Seoul, Korea, Republic of
|
| 8 |
NCT02372136 |
Recruiting |
Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants |
- Infant, Premature, Diseases
- Infant, Small for Gestational Age
|
- Dietary Supplement: Individualized Nutrition
- Dietary Supplement: Optimized nutrition
|
Interventional |
Not Applicable |
- University of Texas Southwestern Medical Center
- Children's Medical Center Dallas
- The Gerber Foundation
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Growth velocity
- Disproportionate growth (increased fat mass)
- Blood pressure
- (and 10 more...)
|
150 |
All |
up to 7 Days (Child) |
NCT02372136 |
STU 102014-056 |
|
January 2016 |
July 2018 |
July 2021 |
February 26, 2015 |
February 14, 2017 |
|
- UT Southwestern Medical Center
Dallas, Texas, United States
|
| 9 |
NCT02326610 |
Not yet recruiting |
Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae |
- Infant, Small for Gestational Age
- Growth Hormone Treatment
- Infant, Premature, Diseases
|
- Drug: Human growth hormone,ZOMACTON® (somatropin)
|
Interventional |
Phase 2 |
- Tel-Aviv Sourasky Medical Center
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Changes in Cognitive assessments (using the Bayley Scales of Infant Development (BSID-III)
- Changes in Neurological status (formal neurological examination)
- Changes in X-ray of the hand and wrist
- (and 2 more...)
|
20 |
All |
6 Months to 12 Months (Child) |
NCT02326610 |
TASMC-14-DM-0713-12-TLV |
hGH |
December 2014 |
December 2017 |
December 2018 |
December 29, 2014 |
December 29, 2014 |
|
|
| 10 |
NCT03456765 |
Recruiting |
Fetal Kidney in Estimation of GA |
- Gestational Age and Maturity
|
- Diagnostic Test: Ultrasound
|
Observational |
|
- Aljazeera Hospital
- Kasr El Aini Hospital
- National Research Center, Egypt
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- The number of participants who will have accurate GA calculated by Kidney parameters
|
350 |
Female |
18 Years to 42 Years (Adult) |
NCT03456765 |
fetal kidney |
|
March 12, 2018 |
October 15, 2018 |
October 20, 2018 |
March 7, 2018 |
April 11, 2018 |
|
|
| 11 |
NCT02534194 |
Recruiting |
Gestational Age Assessment Tool |
- Immature Newborn
- Premature Birth
|
|
Observational |
|
- University of Nottingham
- Bill and Melinda Gates Foundation
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Software analysis tool estimates the gestational age of a newborn baby to within 1 week of its actual gestation
- Quantification of pain from facial features during uncomfortable procedures.
|
150 |
All |
up to 6 Months (Child) |
NCT02534194 |
15020 |
GestATion |
August 2015 |
March 2018 |
August 2018 |
August 27, 2015 |
September 12, 2017 |
|
- Nottingham University Hospitals NHS Trust
Nottingham, Nottinghamshire, United Kingdom
|
| 12 |
NCT02851472 |
Not yet recruiting |
Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO |
|
- Drug: Inhaled Nitric Oxide
- Drug: Placebo
|
Interventional |
Phase 1
Phase 2 |
- New York Medical College
- Stony Brook University
- Baystate Medical Center
- (and 2 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Increased NIRS oxygenation after a PRBC transfusion in iNO treated neonates vs Placebo
- Lower fractional tissue oxygen extraction (FTOE) in iNO treated neonates after PRBC transfusion vs Placebo
|
50 |
All |
Child, Adult, Senior |
NCT02851472 |
FDA IND 126254 |
iNO-TRAGI |
September 2016 |
September 2018 |
June 2019 |
August 1, 2016 |
August 1, 2016 |
|
- Maria Fareri Childrens Hospital
Valhalla, New York, United States
|
| 13 |
NCT03231904 |
Not yet recruiting |
Maternal and Fetal Adrenocorticotropic Hormone (ACTH) and Leukemia Inhibitory Factor (LIF) and Gestational Age |
|
- Diagnostic Test: Blood test
|
Observational |
|
- Rambam Health Care Campus
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Maternal LIF levels during pregnancy
- Maternal ACTH levels during pregnancy
- Fetal LIF levels during pregnancy
- Fetal ACTH levels during pregnancy
|
50 |
Female |
18 Years to 44 Years (Adult) |
NCT03231904 |
0508-16-RMB |
|
August 10, 2017 |
November 30, 2017 |
December 31, 2017 |
July 27, 2017 |
August 4, 2017 |
|
|
| 14 |
NCT02662517 |
Recruiting |
Growth Hormones and Cells in Human Milk Depending on Gestational Age |
|
|
Observational |
|
- University Hospital of Cologne
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- neurotrophins composition
- Amount of cells positive for surface markers TRA-1-81 and SSEA-4
|
100 |
Female |
18 Years and older (Adult, Senior) |
NCT02662517 |
UHCologne |
BMProfile |
March 2016 |
September 2017 |
December 2017 |
January 25, 2016 |
May 5, 2017 |
|
- Neonatology at the University Hospital of Cologne
Cologne, Germany
|
| 15 |
NCT02851979 |
Recruiting |
Odors to Insufflate Life |
- Premature Newborns With Gestational Age 28 to 33 Weeks
|
- Other: Olfactory stimulations
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Number of respiratory pauses between S1 and S2
- difference of the number of apnea episodes between S1 and S2
- difference of the number of apnea episodes between S0 and S2
- adverse events
|
60 |
All |
Child, Adult, Senior |
NCT02851979 |
69HCL16_0078 |
PREMODEUR |
April 2018 |
April 2019 |
October 2019 |
August 2, 2016 |
April 18, 2018 |
|
- Hopital Femme Mère Enfant
Bron, France - CHU de Saint-Etienne
Saint-Étienne, France
|
| 16 |
NCT03385863 |
Recruiting |
Efficacy of Surfactant and Perinatal Risk Factors in NRDS With Different Gestational Ages |
|
- Drug: Surfactant, Pulmonary，Curosurf
- Other: Perinatal risk factors of NRDS
|
Observational |
|
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
|
Other |
- Observational Model: Case-Only
- Time Perspective: Retrospective
|
- therapeutic effect of pulmonary surfactant of infants at different gestational ages
|
1500 |
All |
up to 28 Days (Child) |
NCT03385863 |
02333669 |
|
January 1, 2011 |
December 30, 2016 |
March 1, 2018 |
December 29, 2017 |
December 29, 2017 |
|
- Department of pediatrics, Daping Hospital, The Third Military Medical University
Chongqing, Chongqing, China
|
| 17 |
NCT02745093 |
Not yet recruiting |
Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks |
|
- Drug: Mifepristone
- Drug: Misoprostol
|
Interventional |
Phase 4 |
- Ibis Reproductive Health
- Marie Stopes International
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Proportion of participants with complete abortion without surgical intervention by day 30 from mifepristone administration, regardless of misoprostol dosing, by gestational age group
- Experience of any major adverse event overall, and by type (emergency room treatment, hospitalization, transfusion, unrecognized ectopic pregnancy, allergic reaction, infection requiring intravenous treatment, and death), by gestational age group
- Proportion of participants by gestational age group with complete abortion without surgical intervention after 1, 2, 3, 4, and 5 doses of misoprostol, by gestational age group
- (and 20 more...)
|
648 |
Female |
18 Years and older (Adult, Senior) |
NCT02745093 |
MSI-6103 |
|
September 2016 |
December 2016 |
December 2016 |
April 20, 2016 |
June 20, 2016 |
|
- Marie Stopes Mexico Azcapotzalco
Del. Azcapotzalco, Mexico Distrito Federal, Mexico - Marie Stopes Mexico Roma
Del. Cuauhtémoc, Mexico Distrito Federal, Mexico - Marie Stopes Mexico Pedregal
Del. Tlalpan, Mexico Distrito Federal, Mexico
|
| 18 |
NCT03109444 |
Recruiting |
Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound |
|
- Diagnostic Test: Hip Ultrasound
|
Observational |
|
- University of California, San Francisco
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Alpha Angle in degrees
- Percent Coverage
|
75 |
All |
up to 6 Weeks (Child) |
NCT03109444 |
Hip Growth Chart |
|
October 25, 2017 |
October 1, 2018 |
December 31, 2018 |
April 12, 2017 |
October 27, 2017 |
|
- Community Regional Medical Center
Fresno, California, United States
|
| 19 |
NCT03172104 |
Recruiting |
Neurobehavioural Development of Infants Born <30 Weeks Gestational Age Between Birth and Five Years of Age |
- Preterm Infant
- Motor Activity
- Neurodevelopmental Disorders
- Developmental Coordination Disorder
|
|
Observational |
|
- Murdoch Childrens Research Institute
- University of Melbourne
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Motor development
- Physical Activity
- Pediatric Evaluation of Disability Inventory
- (and 2 more...)
|
300 |
All |
up to 5 Years (Child) |
NCT03172104 |
HREC34147E |
VIBeS-2 |
January 1, 2011 |
May 31, 2019 |
May 31, 2019 |
June 1, 2017 |
June 1, 2017 |
|
- Murdoch Childrens Research Institute
Parkville, Victoria, Australia
|
| 20 |
NCT02774434 |
Recruiting |
Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age |
- Hyperbilirubinemia
- Neonatal Jaundice
|
|
Interventional |
Not Applicable |
- Draeger Medical Systems, Inc.
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Screening
|
- Accuracy of TcB measured with the JM-105 device in predicting the Serum Bilirubin measurements performed on blood samples
- Normalized curve of TSB measurements using the JM-105
- Influence of phototherapy on TSB measurements
|
400 |
All |
24 Weeks to 40 Weeks (Child) |
NCT02774434 |
JM-105 Study |
|
November 2016 |
February 2018 |
April 2018 |
May 17, 2016 |
February 1, 2018 |
|
- Saint Michael's Hospital
Toronto, Ontario, Canada - Mount Sinai Hospital
Toronto, Ontario, Canada - Hamilton Health Science Centre
Toronto, Ontario, Canada
|
| 21 |
NCT02315820 |
Not yet recruiting |
Induction of Labor Versus Expectant Management of Large for Gestational Age/Macrosomic Babies at Term. A Multi-center Trial |
- Macrosomia
- Induction of Labor
- Expectant Management
- Shoulder Dystocia
|
- Procedure: Induction of labor group (Group I)
|
Interventional |
Not Applicable |
- The Baruch Padeh Medical Center, Poriya
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Rate of shoulder dystocia
- Neonatal morbidity composite outcome and maternal morbidity composite outcome.
|
474 |
Female |
18 Years to 45 Years (Adult) |
NCT02315820 |
POR-0085-14 |
IOLEMMT |
January 2015 |
December 2018 |
July 2019 |
December 12, 2014 |
December 12, 2014 |
|
|
| 22 |
NCT03422081 |
Recruiting |
Growth and Asymmetric diMethylArginine |
- Growth Hormone Deficiency
- Small-for-gestational Age
|
- Diagnostic Test: arterial doppler ultrasound
|
Observational |
|
- University Hospital, Lille
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Plasma Asymmetric Dimethylarginine (ADMA)
- Percentage of dilation of the brachial artery at Doppler ultrasound examination.
- Difference of ADMA concentration between the patient and the control groups
- Correlation of ADMA levels with diverse cardiovascular risk factors
|
90 |
All |
3 Years to 18 Years (Child, Adult) |
NCT03422081 |
2012_61
2013-A00830-45 |
GAMMA |
June 2014 |
December 2020 |
December 2020 |
February 5, 2018 |
February 5, 2018 |
|
- Hôpital Jeanne de Flandre - CHRU de Lille
Lille, France - CHU Purpan
Toulouse, France
|
| 23 |
NCT03153839 |
Recruiting |
Influence of the Aquatic Physical Activity for the Neurologic Development of the Babies |
- Infant Behavior
- Gestational Age Over 30 Weeks
|
- Behavioral: Aquatic physical activity in babies
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Evaluation of baby development
- Evaluation of the development of affectivity
- Gestational age
- (and 8 more...)
|
145 |
All |
3 Months to 12 Months (Child) |
NCT03153839 |
25/11/2016 UGR |
|
October 2016 |
July 2017 |
November 2017 |
May 15, 2017 |
May 15, 2017 |
|
- Universidad de Granda
Granada, Spain
|
| 24 |
NCT01825499 |
Recruiting |
Vermont Oxford Network Very Low Birth Weight Database |
|
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Registry of baseline and outcome data for VLBW infants with data collected in a uniform manner
|
60000 |
All |
up to 28 Days (Child) |
NCT01825499 |
VON001 |
VON VLBW |
January 1990 |
December 2040 |
December 2040 |
April 5, 2013 |
May 10, 2017 |
|
- Vermont Oxford Network
Burlington, Vermont, United States
|
| 25 |
NCT02553577 |
Recruiting |
Impact of Electronic Cigarettes on Perinatal Immune Responsiveness and Birth Outcomes |
- Immune Response
- Birth Weight
- Gestational Age
|
|
Observational |
|
- Kristin Ashford
- Virginia Commonwealth University
- University of Kentucky
|
Other |
- Observational Model: Other
- Time Perspective: Prospective
|
- Gestational age at birth
- Infant birth weight
- Change in Prenatal Cytokine level in each trimester and postpartum
|
360 |
Female |
18 Years to 44 Years (Adult) |
NCT02553577 |
1R01DA040694-01 |
|
September 2015 |
August 2019 |
August 2019 |
September 17, 2015 |
June 23, 2017 |
|
- University of Kentucky Prenatal Clinics, Good Samaritian and Polk Dalton
Lexington, Kentucky, United States
|
| 26 |
NCT02563717 |
Recruiting |
Comparison Of Respiratory Support After Delivery on Infants Born Before 28 Weeks Gestational Age |
- Respiration; Insufficient or Poor, Newborn
- Infant, Premature, Diseases
|
- Device: T-piece used for respiratory support (several manufacturers)
- Device: New system used for respiratory support
|
Interventional |
Not Applicable |
- Baldvin Jonsson
- Karolinska Institutet
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Delivery room intubation or death
- Time to primary outcome (intubation or death)
- Death
- (and 4 more...)
|
250 |
All |
Child, Adult, Senior |
NCT02563717 |
2015/927-31/4 |
CORSAD |
March 2016 |
December 2018 |
December 2018 |
September 30, 2015 |
December 13, 2017 |
|
- Department of neonatology, University Hospital of Iceland
Reykjavík, Iceland - Neonatal Unit, Vilnius University Hospital Santaros Klinikos
Vilnius, Lithuania - Stavanger University Hospital, Department of Pediatrics
Stavanger, Norway - (and 3 more...)
|
| 27 |
NCT01534481 |
Recruiting |
Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants |
- Infant, Newborn
- Infant, Small for Gestational Age
- Infant, Extremely Low Birth Weight
|
- Biological: Donor Milk
- Dietary Supplement: Preterm Formula
|
Interventional |
Phase 3 |
- NICHD Neonatal Research Network
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Neurodevelopmental Outcome
- In Hospital Morbidities
- Growth outcomes
- Follow-up Outcomes
|
670 |
All |
up to 21 Days (Child) |
NCT01534481 |
NICHD-NRN-0047
U10HD021364
U10HD040689
U10HD021385
U10HD027851
U10HD027853
U10HD027856
U10HD027904
U10HD027880
U10HD034216
U10HD021373
U10HD040492
U10HD053109
U10HD040461
U10HD068244
U10HD068263
U10HD068278
U10HD068284
U10HD036790 |
|
August 2012 |
June 2019 |
June 2020 |
February 16, 2012 |
November 9, 2017 |
|
- University of Alabama at Birmingham
Birmingham, Alabama, United States - Stanford University
Palo Alto, California, United States - Emory University
Atlanta, Georgia, United States - (and 14 more...)
|
| 28 |
NCT03304782 |
Recruiting |
Fitbit Activity Tracker to Predict Risk of Preterm Birth |
- Preterm Birth
- Preterm Delivery
|
- Other: Fitbit activity tracker
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Difference in number of steps
- Average number of steps for those women who deliver prior to 37 weeks gestation
- Average number of steps for those women who delivery prior to 34 weeks gestation
- (and 6 more...)
|
126 |
Female |
18 Years and older (Adult, Senior) |
NCT03304782 |
AAAR3883 |
|
October 24, 2017 |
March 30, 2019 |
July 30, 2019 |
October 9, 2017 |
January 26, 2018 |
|
- Columbia University Medical Center
New York, New York, United States
|
| 29 |
NCT03078439 |
Recruiting |
EPIPAGE2 Cohort Study Follow up at Five and a Half Years |
|
- Other: Medical and neuropsychological assessments
|
Observational |
|
- Institut National de la Santé Et de la Recherche Médicale, France
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Health disorders assessed by medical exam
- Motor disorders assessed by medical exam
- Cognitive disorders assessed by psychological testing
- (and 4 more...)
|
5201 |
All |
5 Years to 6 Years (Child) |
NCT03078439 |
C15-95
IDRCB |
EPIPAGE2 |
September 2016 |
December 2018 |
December 2018 |
March 13, 2017 |
March 15, 2018 |
|
- Centre Hopsitalier d'Agen
Agen, France - CAMSP Albi
Albi, France - CHU Amiens
Amiens, France - (and 95 more...)
|
| 30 |
NCT02729844 |
Recruiting |
Neolifes Heart - Pulmonary Hypertension in Preterm Children |
- Pulmonary Hypertension
- Bronchopulmonary Dysplasia
|
|
Observational |
|
- University Medical Center Groningen
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Incidence of pulmonary hypertension
- Mortality
- Morbidity
|
165 |
All |
up to 7 Days (Child) |
NCT02729844 |
201500715 |
|
June 2016 |
April 2019 |
April 2019 |
April 6, 2016 |
February 21, 2018 |
|
- University Medical Centre Groningen
Groningen, Netherlands
|
| 31 |
NCT03400670 |
Recruiting |
Comparison of Two Different NCPAP Methods in Preterm Infants With Respiratory Distress Syndrome |
|
|
Interventional |
Not Applicable |
- Zekai Tahir Burak Women's Health Research and Education Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- noninvasive ventilation failure
|
220 |
All |
up to 2 Hours (Child) |
NCT03400670 |
02082019 |
(NCPAP) |
January 15, 2018 |
February 5, 2018 |
December 5, 2018 |
January 17, 2018 |
January 17, 2018 |
|
- Zekai Tahir Burak Maternity Teaching
Ankara, Turkey
|
| 32 |
NCT01150396 |
Recruiting |
Prognosis of Extremely Premature Birth |
- Infant, Premature, Diseases
- Perinatal Morbidity
- Development
- Problem;Growth
|
|
Observational |
|
- University of Bergen
- Haukeland University Hospital
- Helse Stavanger HF
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
|
160 |
All |
22 Weeks to 27 Weeks (Child) |
NCT01150396 |
2010/496 |
BabyPEP |
July 2010 |
December 2017 |
December 2018 |
June 25, 2010 |
June 2, 2015 |
|
- Haukeland University Hospital
Bergen, Norway - Stavanger University Hospital
Stavanger, Norway
|
| 33 |
NCT03195998 |
Not yet recruiting |
Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants |
|
- Diagnostic Test: TcB Measurement
|
Observational |
|
- Mednax Center for Research, Education, Quality and Safety
- Banner University Medical Center
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- validity of transcutaneous bilirubin measurements
- treatment with phototherapy
- cost savings
|
60 |
All |
23 Weeks to 34 Weeks (Child) |
NCT03195998 |
16NE-GSAM-6364 |
TcB |
June 30, 2017 |
February 1, 2019 |
February 1, 2019 |
June 22, 2017 |
June 22, 2017 |
|
- Banner - University Medical Center Phoenix
Phoenix, Arizona, United States
|
| 34 |
NCT03360292 |
Not yet recruiting |
Measuring Oxygenation of Newborn Infants in Targeted Oxygen Ranges |
- Premature Infant
- Hypoxia
- Hyperoxia
|
- Other: Higher target range
|
Interventional |
Not Applicable |
- University of Edinburgh
- NHS Lothian
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Incidence of hyperoxia and hypoxia on saturations
- Incidence of hyperoxia and hypoxia on Transcutaneous monitoring
- Saturation variability
- (and 4 more...)
|
20 |
All |
up to 1 Month (Child) |
NCT03360292 |
AC17098
194632 |
MONITOR |
February 1, 2018 |
August 1, 2019 |
August 1, 2019 |
December 4, 2017 |
December 5, 2017 |
|
- Neonatal Unit - Royal Infirmary of Edinburgh
Edinburgh, Lothian, United Kingdom
|
| 35 |
NCT03171324 |
Recruiting |
to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Infants |
|
|
Interventional |
Phase 4 |
- Deepanjan Bhattacharya
- Postgraduate Institute of Medical Education and Research
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Other
|
- Iron deficiency anemia
- Growth parameter1
- Growth parameter2
- (and 5 more...)
|
300 |
All |
6 Weeks to 1 Year (Child) |
NCT03171324 |
Deep1234 |
|
March 1, 2017 |
June 30, 2018 |
June 30, 2018 |
May 31, 2017 |
June 1, 2017 |
|
|
| 36 |
NCT02901652 |
Not yet recruiting |
NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome |
- Prematurity
- Respiratory Distress Syndrome
|
- Device: SLE; Specialised Laboratory Equipment
|
Interventional |
Phase 4 |
- Zekai Tahir Burak Women's Health Research and Education Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- surfactant requirement within the first 72 hours of life
|
160 |
All |
up to 3 Days (Child) |
NCT02901652 |
02082016 |
|
September 2016 |
September 2017 |
October 2017 |
September 15, 2016 |
September 15, 2016 |
|
|
| 37 |
NCT02907632 |
Recruiting |
Methoclopramide for Gastroesophageal Reflux in Premature Infants |
|
- Drug: Metoclopramide
- Drug: Placebo
|
Interventional |
Phase 4 |
- Nathalie Charpak
- Hospital Universitario San Ignacio
- Pontificia Universidad Javeriana
- Kangaroo Foundation
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Incidence of regurgitation episodes
- Episodes of apnea
- Bronchoaspiration
- (and 3 more...)
|
520 |
All |
up to 100 Days (Child) |
NCT02907632 |
2015/71 |
|
June 1, 2017 |
July 31, 2018 |
December 31, 2018 |
September 20, 2016 |
March 26, 2018 |
|
- Nathalie Charpak
Bogotá, Cundinamarca, Colombia
|
| 38 |
NCT02853253 |
Not yet recruiting |
Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and Medialipide |
|
- Dietary Supplement: SMOFlipid®
- Dietary Supplement: Medialipide®
|
Interventional |
Phase 4 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Rate of other free radical diseases
- Weight gain
- Growth velocity
- Head circumference growth velocity
|
484 |
All |
up to 1 Day (Child) |
NCT02853253 |
69HCL16_0135 |
SMOF |
January 2017 |
May 2019 |
May 2019 |
August 2, 2016 |
August 2, 2016 |
|
- Hopital Femme Mère Enfant
Bron, France
|
| 39 |
NCT03395639 |
Recruiting |
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease |
- Anticoagulant Drugs
- Cardiac Disease
|
- Drug: Edoxaban
- Drug: Standard of Care (SOC)
|
Interventional |
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Number of participants with combined bleeding events within the main treatment period
- Number of participants with combined bleeding events during the entire trial (from first to the last dose plus 30 days)
- Number of participants with symptomatic thromboembolic events (TE) in the systemic arterial or venous pathways
- (and 2 more...)
|
150 |
All |
up to 17 Years (Child) |
NCT03395639 |
DU176b-C-U313
2017-000475-90 |
|
November 17, 2017 |
March 2021 |
March 2021 |
January 10, 2018 |
March 29, 2018 |
|
- University of Alabama at Birmingham
Birmingham, Alabama, United States - Cardon Childrens Medical Center
Mesa, Arizona, United States - Cedars Sinai Medical Center (ECG)
Los Angeles, California, United States - (and 75 more...)
|
| 40 |
NCT01793129 |
Recruiting |
Preemie Hypothermia for Neonatal Encephalopathy |
- Infant, Newborn
- Hypoxia, Brain
- Hypoxia-Ischemia, Brain
- (and 3 more...)
|
- Device: Hypothermia
- Procedure: Normothermic Control
|
Interventional |
Phase 2
Phase 3 |
- NICHD Neonatal Research Network
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Death or moderate or severe disability
- Number of deaths in the NICU and following discharge
- Differences in MRI findings after cessation of cooling/control obtained
- (and 3 more...)
|
168 |
All |
33 Weeks to 35 Weeks (Child) |
NCT01793129 |
NICHD-NRN-0051
U10HD021364
U10HD040689
U10HD021385
U10HD027851
U10HD027853
U10HD027856
U10HD027904
U10HD027880
U10HD034216
U10HD021373
U10HD040492
U10HD053109
U10HD040461
U10HD068244
U10HD068263
U10HD068270
U10HD068278
U10HD068284
U10HD036790
UG1HD087226 |
|
May 2015 |
August 2020 |
October 2022 |
February 15, 2013 |
January 26, 2018 |
|
- University of Alabama at Birmingham
Birmingham, Alabama, United States - Stanford University
Palo Alto, California, United States - Emory University
Atlanta, Georgia, United States - (and 15 more...)
|
| 41 |
NCT02887846 |
Not yet recruiting |
Comparing HHHFNC and nCPAP Ventilation Methods for the Prevention of Extubation Failure in Preterm Infants |
- Extubation Failure
- Prematurity
|
- Device: Heated Humidified High-Flow Nasal Cannula
|
Interventional |
Phase 4 |
- Zekai Tahir Burak Women's Health Research and Education Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
|
200 |
All |
up to 7 Days (Child) |
NCT02887846 |
11082016 |
|
August 2016 |
July 2017 |
September 2017 |
September 2, 2016 |
September 13, 2016 |
|
|
| 42 |
NCT02092688 |
Recruiting |
Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth |
- Preterm Labour
- Preterm Birth
|
- Device: novel kit for the detection of PAMG-1
|
Observational |
|
- University Hospital Inselspital, Berne
- AmniSure International LLC
|
Other |
- Observational Model: Case Control
- Time Perspective: Prospective
|
- Time to delivery
- Number of patients who have a positive PAMG-1-Test and deliver within 48 hours, 7 days and 14 days after taking the test
- Number of patients who have a negative PAMG-1-Test and do not deliver within 48 hours, 7 days and 14 days after taking the test
- (and 12 more...)
|
120 |
Female |
18 Years and older (Adult, Senior) |
NCT02092688 |
140/13 |
|
December 2013 |
August 2017 |
October 2017 |
March 20, 2014 |
August 31, 2016 |
|
- Prof. Dr. Daniel Surbek
Bern, Switzerland
|
| 43 |
NCT00063063 |
Recruiting |
Generic Database of Very Low Birth Weight Infants |
- Infant, Newborn
- Infant, Low Birth Weight
- Infant, Small for Gestational Age
- Infant, Premature
|
|
Observational |
|
- NICHD Neonatal Research Network
- National Center for Research Resources (NCRR)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Other / NIH |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- To maintain a registry of baseline and outcome data for VLBW infants with data collected in a uniform manner
- To examine the relationship between baseline characteristics and outcome
- To monitor trends in incidence of various disease entities
- (and 2 more...)
|
80000 |
All |
up to 14 Days (Child) |
NCT00063063 |
NICHD-NRN-0001
U01HD019897
U01HD021466
U10HD021364
U10HD021373
U10HD021385
U10HD021397
U10HD021415
U01HD021438
U10HD027851
U10HD027853
U10HD027856
U10HD027871
U10HD027880
U10HD027881
U10HD027904
U10HD034167
U10HD034216
U10HD036790
U10HD040461
U10HD040492
U10HD040498
U10HD040521
U10HD040689
U10HD042638
U10HD053089
U10HD053109
U10HD053119
U10HD053124
UL1RR024139
UL1RR025744
M01RR000032
M01RR000039
M01RR000044
M01RR000054
M01RR000059
M01RR000064
M01RR000070
M01RR000080
M01RR000633
M01RR000750
M01RR000997
M01RR008084
M01RR001032
M01RR002172
M01RR002635
M01RR007122
M01RR016587
U10HD068244
U10HD068263
U10HD068270
U10HD068278
U10HD068284
UG1HD034216
UG1HD027904
UG1HD021364
UG1HD027853
UG1HD040689
UG1HD040492
UG1HD027851
UG1HD087229
UG1HD027856
UG1HD053109
UG1HD068284
UG1HD068278
UG1HD068244
UG1HD068263
UG1HD027880
UG1HD068270
UG1HD053089
UG1HD087226 |
GDB |
January 1987 |
March 2021 |
March 2021 |
June 20, 2003 |
August 15, 2017 |
|
- University of Alabama at Birmingham
Birmingham, Alabama, United States - University of California - Los Angeles
Los Angeles, California, United States - Stanford University
Palo Alto, California, United States - (and 25 more...)
|
| 44 |
NCT00009633 |
Recruiting |
Follow-up Visit of High Risk Infants |
- Infant, Newborn
- Infant, Low Birth Weight
- Infant, Small for Gestational Age
- Infant, Premature
|
|
Observational |
|
- NICHD Neonatal Research Network
- National Center for Research Resources (NCRR)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Other / NIH |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- To maintain a registry of baseline and outcome data for VLBW infants with data collected in a uniform manner
- To examine the relationship between baseline characteristics and outcome
- To provide data for hypothesis formulation and sample size calculation for Network multi-center studies
|
68000 |
All |
18 Months to 26 Months (Child) |
NCT00009633 |
NICHD-NRN-0007
U01HD019897
U01HD021466
U10HD021364
U10HD021373
U10HD021385
U10HD021397
U10HD021415
U01HD021438
U10HD027851
U10HD027853
U10HD027856
U10HD027871
U10HD027880
U10HD027881
U10HD027904
U10HD034167
U10HD034216
U10HD036790
U10HD040461
U10HD040492
U10HD040498
U10HD040521
U10HD040689
U10HD042638
U10HD053089
U10HD053109
U10HD053119
U10HD053124
UL1RR024139
UL1RR025744
M01RR000633
M01RR000750
M01RR000997
M01RR008084
M01RR001032
M01RR002172
M01RR002635
M01RR007122
M01RR016587
UG1HD087226 |
FU |
January 1993 |
March 2021 |
March 2021 |
February 5, 2001 |
November 9, 2017 |
|
- University of Alabama at Birmingham
Birmingham, Alabama, United States - University of California - Los Angeles
Los Angeles, California, United States - Stanford University
Palo Alto, California, United States - (and 25 more...)
|
| 45 |
NCT01604395 |
Recruiting |
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children |
- Growth Hormone Deficiency
- Turner Syndrome
- Chronic Renal Failure
- (and 2 more...)
|
|
Observational |
|
|
Industry |
- Observational Model: Cohort
|
- Safety measure : adverse event
- effectiveness measure : difference in target height and final height
- effectiveness : difference in height velocity between Baseline and every year
- effectiveness measure : difference in height SDS for CA between baseline and every 6 months
|
2000 |
All |
2 Years and older (Child, Adult, Senior) |
NCT01604395 |
LG-HGOS001 |
LGS |
January 2012 |
January 2020 |
January 2022 |
May 23, 2012 |
March 23, 2016 |
|
- Seoul National University Hospital
Seoul, Korea, Republic of
|
| 46 |
NCT03015909 |
Recruiting |
Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. |
- Short Stature, Idiopathic
- Infant, Small for Gestational Age
- Growth Hormone Deficiency
- (and 2 more...)
|
|
Interventional |
Phase 4 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Ease of use for EutropinPen Inj. against previous reusable pen assessed by a questionnaire.
- Preference for EutropinPen Inj. against previous reusable pen assessed by a questionnaire.
- Benefits of EutropinPen inj. assessed by a questionnaire.
- (and 2 more...)
|
116 |
All |
4 Years to 15 Years (Child) |
NCT03015909 |
LG-HGCL008 |
|
August 2016 |
September 2017 |
February 2018 |
January 10, 2017 |
January 19, 2017 |
|
- Ajou university hospital
Suwon, Gyeong-gi, Korea, Republic of
|
| 47 |
NCT01353313 |
Recruiting |
Hydrocortisone for BPD |
- Infant, Newborn
- Infant, Small for Gestational Age
- Infant, Very Low Birth Weight
- (and 2 more...)
|
- Drug: Hydrocortisone
- Drug: Placebo
|
Interventional |
Phase 3 |
- NICHD Neonatal Research Network
- National Center for Research Resources (NCRR)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Heart, Lung, and Blood Institute (NHLBI)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Prevention
|
- Efficacy
- Safety
- Morbidity and Growth
- (and 3 more...)
|
800 |
All |
up to 30 Weeks (Child) |
NCT01353313 |
NICHD-NRN-0045
U10HD034216
U10HD027904
U10HD021364
U10HD027853
U10HD040689
U10HD040492
U10HD027851
U10HD021373
U10HD027856
U10HD053109
U10HD036790
U10HD027880
U10HD053089
U10HD021385
U10HD068244
U10HD068263
U10HD068270
U10HD068278
U10HD068284
U24HL137729
1UG3HL137872 |
|
September 2011 |
January 2020 |
January 2025 |
May 13, 2011 |
December 15, 2017 |
|
- University of Alabama at Birmingham
Birmingham, Alabama, United States - University of California - Los Angeles
Los Angeles, California, United States - Stanford University
Palo Alto, California, United States - (and 17 more...)
|
| 48 |
NCT03082313 |
Recruiting |
Movement-based Infant Intervention |
- Infant Development
- Infant,Premature
- Infant, Very Low Birth Weight
- (and 2 more...)
|
- Behavioral: Movement Intervention
|
Interventional |
Not Applicable |
- University of Southern California
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Movement rate
- Motor development rate
|
12 |
All |
3 Months to 9 Months (Child) |
NCT03082313 |
HS-16-00959 |
|
September 1, 2017 |
December 31, 2019 |
December 31, 2019 |
March 17, 2017 |
October 26, 2017 |
|
- Infant Neuromotor Control Laboratory
Los Angeles, California, United States
|
| 49 |
NCT02382601 |
Recruiting |
Longitudinal Study of Intra-Uterine Growth Restriction |
|
- Radiation: Ultrasound
- Radiation: MRI
- Procedure: Blood collection
- (and 3 more...)
|
Observational |
|
- University of Colorado, Denver
- The Perelman Family Foundation
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Characterize the sequence of neurological and cardiovascular events defining early and late IUGR pathogenesis, respectively
- Correlate in utero adaptations in early and late IUGR, to infant and early childhood neurodevelopment
- Correlate in utero adaptations in early and late IUGR, to infant and early childhood cardiovascular outcomes
- (and 2 more...)
|
200 |
Female |
18 Years to 45 Years (Adult) |
NCT02382601 |
14-1360 |
|
April 2015 |
July 2019 |
December 2019 |
March 9, 2015 |
August 31, 2017 |
|
- University of Colorado Denver Anschutz Medical Campus
Aurora, Colorado, United States
|
| 50 |
NCT03215173 |
Recruiting |
Fit After Baby: A Health Intervention to Increase Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease |
- Cardiovascular Diseases
- Diabetes
- Gestational Diabetes
- (and 5 more...)
|
- Behavioral: Fit After Baby
- Behavioral: Text4Baby Control Group
|
Interventional |
Not Applicable |
- University of Colorado, Denver
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Change in weight loss from baseline to one year postpartum
- Change in postpartum weight retention
- Evaluation of Subject Satisfaction
- (and 19 more...)
|
120 |
Female |
18 Years to 45 Years (Adult) |
NCT03215173 |
17-0045 |
FAB |
September 1, 2017 |
December 31, 2020 |
December 31, 2021 |
July 12, 2017 |
November 6, 2017 |
|
- University of Colorado
Aurora, Colorado, United States
|
Create an RSS feed from your search for:
Download the search results for: